Huntington's Disease – Drug Pipeline Analysis and Market Forecasts …
March 16th, 2010 by blereoglems
The Huntington’s Disease Market is Forecast to Show High Growth Until 2016.
Scientists discover primitive organism to help with disease research (People’s Daily)
March 15th, 2010 by intextbon
A newly discovered primitive organism can be used in medical research in battling Huntington’s disease and Alzheimer’s disease, said a report released on Saturday.
Huntington’s disease group to discuss drug (The Fargo Forum)
March 13th, 2010 by cjoelprounding
The Huntington’s disease Northern Prairie Advocates will host an informational presentation about the drug Tetrabenazine from 10 a.m. to noon Saturday at Fargo’s Holiday Inn.
Ischemic heart disease: Guide for recognition and management (News-Medical-Net)
March 8th, 2010 by Andrianq
Research and Markets has announced the addition of the “Ischaemic Heart Disease, 1st Revised Edition” report to their offering.
Long-Term Efficacy Of Xenazine® (Tetrabenazine) For The Treatment Of Chorea Associated With Huntington’s Disease (Medical News Today)
March 8th, 2010 by blereoglems
Lundbeck Inc. has announced the presentation of results from an open-label extension study of Xenazine® (tetrabenazine) for the treatment of chorea associated with Huntington’s disease (HD)